231292-09-4 Usage
Derivative of indole-3-acetic acid
Plant hormone 2-(2-Benzoyl-6-chloro-1H-indol-3-yl)acetic acid is derived from indole-3-acetic acid, which is a plant hormone that plays a role in physiological processes such as cell elongation, division, and differentiation.
Benzoyl group
Potential pharmaceutical intermediate The presence of a benzoyl group in the chemical structure suggests that 2-(2-Benzoyl-6-chloro-1H-indol-3-yl)acetic acid could be used as a pharmaceutical intermediate or as a starting material for the synthesis of compounds with biological activity.
Chlorine atom
Structural modification The presence of a chlorine atom in the chemical structure indicates a structural modification compared to the parent compound, indole-3-acetic acid, which may affect its properties and potential applications.
Applications in medicinal chemistry
Drug discovery and agrochemical research Due to its structural resemblance to other biologically active molecules, 2-(2-Benzoyl-6-chloro-1H-indol-3-yl)acetic acid may have applications in the fields of medicinal chemistry, drug discovery, and agrochemical research.
Further research needed
Specific properties and potential uses Although 2-(2-Benzoyl-6-chloro-1H-indol-3-yl)acetic acid shows promise in various scientific and industrial applications, further research is necessary to elucidate its specific properties and potential uses.
Check Digit Verification of cas no
The CAS Registry Mumber 231292-09-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,3,1,2,9 and 2 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 231292-09:
(8*2)+(7*3)+(6*1)+(5*2)+(4*9)+(3*2)+(2*0)+(1*9)=104
104 % 10 = 4
So 231292-09-4 is a valid CAS Registry Number.
231292-09-4Relevant articles and documents
2,3-substituted indole compounds as anti-inflammatory and analgesic agents
-
, (2008/06/13)
This invention provides a compound of the following formula: or the pharmaceutically acceptable salts thereof wherein Z is OH, C1-6 alkoxy, —NR2R3 or heterocycle; Q is selected from the following: (a) an optionally substituted phenyl, (b) an optionally substituted 6-membered monocyclic aromatic group containing one, two, three or four nitrogen atom(s), (c) an optionally substituted 5-membered monocyclic aromatic group containing one heteroatom selected from O, S and N and optionally containing one, two or three nitrogen atom(s) in addition to said heteroatom, (d) an optionally substituted C3-7 cycloalkyl and (e) an optionally substituted benzo-fuzed heterocycle; R1 is hydrogen, C1-4 alkyl or halo; R2 and R3 are independently hydrogen, OH, C1-4 alkoxy, C1-4 alkyl or C1-4 alkyl substituted with halo, OH, C1-4 alkoxy or CN; X is independently selected from H, halo, C1-4 alkyl, halo-substituted C1-4 alkyl, OH, C1-4 alkoxy, halo-substituted C1-4 alkoxy, C1-4 alkylthio, NO2, NH2, di-(C1-4 alkyl)amino and CN; and n is 0, 1, 2, 3 and 4.This invention also provides a pharmaceutical composition useful for the treatment of a medical condition in which prostaglandins are implicated as pathogens.
